Prazosin Alcohol Dependence IVR Study
Public ClinicalTrials.gov record NCT00167687. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind Placebo-Controlled Trial of Prazosin for the Treatment of Alcohol Dependence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This double-blind placebo controlled pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduced alcohol consumption and alcohol craving in alcohol dependent individuals without Post Traumatic Stress Disorder (PTSD). The intervention period is six weeks.
Study identification
- NCT ID
- NCT00167687
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2005
- Primary completion
- Sep 30, 2007
- Completion
- Sep 30, 2007
- Last update posted
- Feb 14, 2008
2005 – 2007
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA Puget Sound Health Care System | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Alcoholism trials
Other public records listing Alcoholism. Sorted by last update posted; newest first. Not a recommendation.
- NCT05747703: Telehealth Treatment for Alcohol Use Disorder Active, not recruiting
- NCT05414240: Ibudilast for Treating Alcohol Use Disorder Active, not recruiting
- NCT06676059: SMART-r: Substance Monitoring and Active Relapse Tracking Repository Recruiting
- NCT02108080: Characterization Imaging Instruments in Alcoholics and Non-Alcoholics Recruiting
- NCT05473598: Stand Down-Think Before You Drink: An RCT of a Mobile App for Hazardous Drinking With Peer Phone Support Active, not recruiting
- NCT02108054: Behavioral and Functional Task Development, Implementation, and Testing Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00167687, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2008 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00167687 live on ClinicalTrials.gov.